Medical Advocates

Ritonavir
(Norvir)
 
Journal Citations: Clinical
Pharmacology

General/Miscellaneous Reports
Pharmacokinetics
Resistance
Cross Resistance
Viral Dynamics
Drug Interactions 
Adverse Events
Efficacy

 


Ritonavir Main Page Drugs Main Page   Home Page    

Last Update:  February 17, 2015
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General/Miscellaneous Reports
 

  The cumulative occurrence of resistance mutations in the HIV-1 protease gene
is associated with failure of salvage therapy with ritonavir and saquinavir in
protease inhibitor-experienced patients
.
Karmochkine M, Si Mohamed A, Piketty C, et al.
Antiviral Res 2000 Sep;47(3):179-88

Abstract

 


Pharmacokinetics
 

 
Effects of the HIV-Protease Inhibitor Ritonavir on Basal and Catecholamine-
Stimulated Lipolysis
Adler-Wailes DC, Liu H, et al 
J Clin Endocrinol Metab. 2005 Mar
Abstract 
 
Ritonavir Decreases the Nonrenal Clearance of Digoxin in Healthy Volunteers
with Known MDR1 Genotypes.
Penzak SR, Shen JM, Alfaro RM, et al
Ther Drug Monit. 2004 Jun;26(3):322-330.
Abstract 
 
Differential effect of HIV protease inhibitors on adipogenesis: intracellular ritonavir
is not sufficient to inhibit differentiation.
Vernochet C, Azoulay S, Duval D, et al
AIDS. 2003 Oct 17;17(15):2177-80.

Abstract 
 
Effects of Ritonavir on Indinavir Pharmacokinetics in Cerebrospinal Fluid and Plasma.
Haas DW, Johnson B, Nicotera J, et al
Antimicrob Agents Chemother. 2003 Jul;47(7):2131-2137.
Abstract 

Pharmacokinetics of Ritonavir and Delavirdine in Human Immunodeficiency Virus-
Infected Patient
s.

Shelton MJ, Hewitt RG, Adams J, et al.
Antimicrob Agents Chemother 2003 May;47(5):1694-1699
Abstract 

Effect of short-term administration of garlic supplements on single-dose ritonavir
pharmacokinetics in healthy volunteers.
Gallicano K, Foster B, Choudhri S. et al.

B
r J Clin Pharmacol 2003 Feb;55(2):199-202
Abstract 

Model-based Analysis of the Pharmacokinetic Interactions Between Ritonavir,
Nelfinavir, and Saquinavir after Simultaneous and Staggered Oral Administration.

Lu JF, Blaschke TF, Flexner C, et al
Abstract  

Ritonavir inhibition of calcium-activated neutral proteases.
Wan W, DePetrillo PB.
Biochem Pharmacol 2002 Apr 15;63(8):1481-1484

Abstract  

Saquinavir and ritonavir pharmacokinetics following combined ritonavir and
saquinavir (soft gelatin capsules) administration.
Buss N, Snell P, Bock J, Hsu A, Jorga K.
Br J Clin Pharmacol 2001 Sep;52(3):255-64
Abstract 

 

Resistance
 

  The cumulative occurrence of resistance mutations in the HIV-1 protease gene
is associated with failure of salvage therapy with ritonavir and saquinavir in
protease inhibitor-experienced patients
.
Karmochkine M, Si Mohamed A, Piketty C, et al.
Antiviral Res 2000 Sep;47(3):179-88

Abstract

Cross Resistance
 

FULL-TEXT ARTICLE
Human immunodeficiency virus type 1 protease cleavage site mutations |
associated with protease inhibitor cross-resistance selected by indinavir
,
ritonavir, and/or saquinavir.

Cote HC, Brumme ZL, Harrigan PR
J Virol 2001 Jan;75(2):589-94
 
Paper

FULL-TEXT ARTICLE
Low level of cross-resistance to amprenavir (141W94) in samples from patients
pretreated with other protease inhibitors
.
Schmidt B, Korn K, Moschik B, et al
Antimicrob Agents Chemother 2000 Nov;44(11):3213-6 
Paper


Viral Dynamics/Response
 

RTV/SQV

Cerebrospinal fluid HIV RNA and drug levels with combination ritonavir
and saquinavir
.
Kravcik S, Gallicano K, Roth V, et al.
J Acquir Immune Defic Syndr 1999 Aug 15;21(5):371-5

Abstract


Diagnostics
 

  Quantification of plasma and intracellular levels of the HIV protease inhibitor
ritonavir by competitive ELISA.

Akeb F, Ferrua B, Creminon C, et al
J Immunol Methods 2002 May 1;263(1-2):1-9
Abstract
 

Efficacy
 

Antitumor Effect
 
  Antitumor effect of the human immunodeficiency virus protease inhibitor ritonavir:
induction of tumor-cell apoptosis associated with perturbation of proteasomal
proteolysis.
Gaedicke S, Firat-Geier E, Constantiniu O, et al.
Cancer Res 2002 Dec 1;62(23):6901-8
Abstract  
 


Ritonavir Main Page Drugs Main Page   Home Page    

  RITONAVIR  
Journal Papers, Abstracts, and Commentaries
Clinical Pharmacology/Main Page